Cover |
Mar. 13, 2024 |
|---|---|
| Cover [Abstract] | |
| Document Type | 8-K/A |
| Amendment Flag | true |
| Amendment Description | Unicycive Therapeutics, Inc. (the “Company”) is filing this Form 8-K/A to its Current Report on Form 8-K as originally filed with the Securities and Exchange Commission on March 14, 2024, (the “Original Filing”), solely to re-file Exhibits 4.2 and 4.3 to correct the Expiration Date on the first page of each such exhibit as the Expiration Date in such exhibits in the Original Filing contained the incorrect expiration dates due to an indavertent clerical error. No other changes have been made from the Original Filing. |
| Document Period End Date | Mar. 13, 2024 |
| Current Fiscal Year End Date | --12-31 |
| Entity File Number | 001-40582 |
| Entity Registrant Name | UNICYCIVE THERAPEUTICS, INC. |
| Entity Central Index Key | 0001766140 |
| Entity Tax Identification Number | 81-3638692 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | 4300 El Camino Real |
| Entity Address, Address Line Two | Suite 210 |
| Entity Address, City or Town | Los Altos |
| Entity Address, State or Province | CA |
| Entity Address, Postal Zip Code | 94022 |
| City Area Code | 650 |
| Local Phone Number | 351-4495 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common stock |
| Trading Symbol | UNCY |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | true |
| Elected Not To Use the Extended Transition Period | false |